Transcriptional induction of rat liver apolipoprotein A-I gene expression by glucocorticoids requires the glucocorticoid receptor and a labile cell-specific protein

European Journal of Biochemistry

Volumn 239, Issue 2, 1996, Pages 451-459

  Saladin, Régis ^a   Vu Dac, Ngoc ^a   Fruchart, Jean Charles ^a   Auwerx, Johan ^a   Staels, Bart ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Apolipoprotein; Corticosteroid hormone; Gene expression; Liver

Indexed keywords

APOLIPOPROTEIN A1; CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLOHEXIMIDE; DACTINOMYCIN; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MIFEPRISTONE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEPATOMA CELL; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA ANALYSIS;

ALOCASIA MACRORRHIZOS; ANIMALIA;

EID: 0030039132     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1996.0451u.x     Document Type: Article

References (63)

1. Gordon, T., Castelli, W. P., Hjörtland, M. C., Kannel, W. B. & Dawber, T. R. (1977) High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study, Am. J. Med. 62, 707-714.
2. Gordon, D. J. & Rifkind, B. M. (1989) High density lipoprotein - the clinical implications of recent studies, N. Engl. J. Med. 321, 1311-1316.
3. Puchois, P., Kandoussi, A., Fievet, P., Fourrier, J. L., Bertrand, M., Koren, E. & Fruchart, J. C. (1987) Apolipoprotein A-I containing lipoproteins in coronary artery disease, Atherosclerosis 68, 35-40.
4. Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G. & Clift, S. M. (1991) Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI, Nature 353, 265-267.
5. Warden, C. H., Hedrick, C. C., Qiao, J. H., Castellani, L. W. & Lusis, A. J. (1993) Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II, Science 261, 469-472.
6. Schultz, J. R., Verstuyft, J. G., Gong, E. L., Nichols, A. V. & Rubin, E. M. (1993) Protein composition determines the anti-atherogenic properties of HDL transgenic mice, Nature 365, 762-764.
7. Staels, B., Auwerx, J., Chan, L., van Tol, A., Rosseneu, M. & Verhoeven, G. (1989) Influence of development, oestrogens and food intake on apolipoprotein A-I, A-II and E mRNA in the rat liver and intestine, J. Lipid Res. 30, 1137-1145.
8. Staels, B., van Tol, A., Chan, L., Will, H., Verhoeven, G. & Auwerx, J. (1990) Alterations in thyroid styrosine aminotransferaseus modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats, Endocrinology 127, 1144-1152.
9. Staels, B., van Tol, A., Chan, L., Verhoeven, G. & Auwerx, J. (1991) Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats, Arterioscler. Thromb. 11, 760-769.
10. Staels, B., van Tol, A., Andreu, T. & Auwerx, J. (1992) Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat, Arterioscler. Thromb. 12, 286-294.
11. Berthou, L., Staels, B., Saldicco, I., Berthelot, I., Casey, J., Fruchart, J.-C., Denèfle, P. & Branellec, D. (1994) Opposite in vitro and in vivo regulation of hepatic apolipoprotein A-I gene expression by retinoic acid. Absence of effects on apolipoprotein A-II gene expression, Arterioscler. Thromb. 14, 1657-1664.
12. Evans, R. M. (1988) The steroid and thyroid hormone receptor superfamily, Science 240, 889-895.
13. Green, S. & Chambon, P. (1986) A superfamily of potentially oncogenic hormone receptors, Nature 324, 615-617.
14. Nashel, D. J. (1986) Is atherosclerosis a complication of long-term corticosteroid treatment? Am. J. Med. 80, 925-929.
15. Zimmerman, J., Fainaru, M. & Eisenberg, S. (1984) The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study, Metabolism 33, 521-526.
16. Taskinen, M.-R., Kuusi, T., Yki-Järvinen, H. & Nikkilä, E. A. (1988) Short-term effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men, J. Clin. Endocrinol. Metab. 67, 291-299.
17. Ettinger, W. H. J. & Hazzard, W. R. (1988) Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men, Metabolism 37, 1055-1058.
18. Ettinger, W. H., Klinefelter, H. F. & Kwiterovich, P. O. (1987) Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids, Atherosclerosis 63, 167-172.
19. Jansen, H., van Tol, A., Auwerx, J., Skretting, G. & Staels, B. (1992) Opposite regulation of hepatic lipase and lecithin :cholesterol acyltransferase by glucocorticoids in rats, Biochim. Biophys. Acta 1128, 181-185.
20. Becker, J. E., de Nechaud, B. & Potter, V. R. (1976) Two new rat hepatoma cell lines for studying the unbalanced blocked ontogeny hypothesis, in Onco-developmental gene expression (Fishman, W. H. & Sell, S., eds) pp. 259-270, Academic Press, New York.
21. Berry, M. N. & Friend, D. S. (1969) High-yield preparation of isolated rat liver parenchymal cells. A biochemical and fine structural study, J. Cell. Biol. 43, 506-520.
22. Chomczynski, P. & Sacchi, N. (1987) Single step method for RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162, 156-159.
23. Luo, C. C., Li, W. H., Moore, M. N. & Chan, L. (1986) Structure and evolution of the apolipoprotein multigene family, J. Mol. Biol. 187, 325-340.
24. Nevins, J. R. (1987) Isolation and analysis of nuclear RNA, Methods Enzymol. 152, 234-241.
25. Haddad, I. A., Ordovas, J. M., Fitzpatrick, T. & Karathanasis, S. K. (1986) Linkage, evolution, and expression of the rat apolipoprotein A-I, C-III, and A-IV genes, J. Biol. Chem. 261, 13268-13277.
26. Ham, J., Thomson, A., Needham, M., Webb, P. & Parker, M. (1988) Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus, Nucleic Acids Res. 16, 5263-5276.
27. Gorman, C. M., Moffat, L. F. & Howard, B. H. (1982) Recombinant genomes which express recombinant chloramphenicol acetyl transferase in mammalian cells, Mol. Cell Biol. 2, 1044-1051.
28. Feve, B., Antras, J., Lasnier, F., Hilliou, F. & Pairault, J. (1989) The antiglucocorticoid RU38486 is a potent accelerator of adipose conversion of 3T3-F422A cells, Mol. Cell. Endocrinol. 67, 17-27.
29. Schweizer-Groyer, G., Cadepond, F., Groyer, A., Idziorek, T., Mariller, M. & Baulieu, E. E. (1988) Stimulation of specific transcription and DNA binding studies suggest that in vitro transformed RU486-glucocorticosteroid receptor complexes display agonist activity, J. Steroid Biochem. 30, 291-294.
30. Simons, S. S. J., Mercier, L., Miller, N. R., Miller, P. A., Oshima, H., Sistare, F. D., Thompson, E. B., Wasner, G. & Yen, P. M. (1989) Differential modulation of gene induction by glucocorticoids and antiglucocorticoids in rat hepatoma tissue culture cells, Cancer Res. 49, 2244S-2252S.
31. Spiegelberg, T. & Bishop, J. O. (1988) Tissue-specific gene expression in mouse hepatocytes cultured in growth-restricting medium, Mol. Cell. Biol. 8, 3338-3344.
32. Alexandrova, M. (1992) Duration of antagonizing effect of RU486 on the agonist induction of tyrosine aminotransferase via glucocorticoid receptor. J. Steroid Biochem. Mol. Biol. 41, 723-725.
33. Widom, R. L., Ladias, J. A., Kouidou, S. & Karathanasis, S. K. (1991) Synergistic interactions between transcription factors control expression of the apolipoprotein A-1 gene in liver cells, Mol. Cell. Biol. 11, 677-687.
34. Chan, J., Nakabayashi, H. & Wong, N. C. W. (1993) HNF-4 increases activity of rat apo A1 gene, Nucleic Acids Res. 21, 1205-1211.
35. Berg, A. & Nilsson-Ehle, P. (1994) Direct effects of corticotropin on plasma lipoprotein metabolism in man - studies in vivo and in vitro, Metabolism 43, 90-97.
36. Parker, C. R. J., MacDonald, P. C., Carr, B. R. & Morrison, J. C. (1987) The effects of dexamethasone and anencephaly on newborn serum levels of apolipoprotein A-I, J. Clin. Endocrinol. Metab. 65, 1098-1101.
37. Elshourbagy, N. A., Boguski, M. S., Liao, W. S. L., Jefferson, L. S., Gordon, J. I. & Taylor, J. M. (1985) Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin, Proc. Natl Acad. Sci. USA 82, 8242-8246.
38. Masumoto, A., Koga, S., Uchida, E. & Ibayashi, H. (1988) Effects of insulin, dexamethasone and glucagon on the production of apolipoprotein A-I in cultured rat hepatocytes, Atherosclerosis 70, 217-223.
39. Lin, R. C. (1988) Effects of hormones on apolipoprotein secretion in cultured rat hepatocytes, Metabolism 37, 745-751.
40. Varma, V. K., Smith, T. K., Sorci-Thomas, M. & Ettinger, W. H. (1992) Dexamethasone increases apolipoprotein A-I concentrations in medium and apolipoprotein A-I mRNA abundance from Hep G2 cells, Metabolism 41, 1075-1080.
41. Lemberger, T., Staels, B., Saladin, R., Desvergne, B., Auwerx, J. & Wahli, W. (1994) Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids, J. Biol. Chem. 269, 24527-24530.
42. Matsuda, T., Noguchi, T., Yamada, K., Takenaka, M. & Tanaka, T. (1990) Regulation of the gene expression of glucokinase and L-type pyruvate kinase in primary cultures of rat hepatocytes by hormones and carbohydrates, J. Biochem. (Tokyo) 108, 778-784.
43. Kurokawa, R., Soderstrom, M., Horlein, A., Halachmi, S., Brown, M., Rosenfeld, M. G. & Glass, C. K. (1995) Polarity-specific activities of retinoic acid receptors determined by a co-repressor, Nature 377, 451-454.
44. Jacq, X., Brou, C., Lutz, Y., Davidson, I., Chambon, P. & Tora, L. (1994) Human TAFII-30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor, Cell 79, 107-117.
45. Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C. & Brown, M. (1994) Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription, Science 264, 1455-1458.
46. Lee, J. W., Ryan, F., Swaffield, J. C., Johnston, S. A. & Moore, D. D. (1995) Interaction of thyroid-hormone receptor with a conserved transcriptional mediator, Nature 374, 91-94.
47. Di Lorenzo, D., Williams, P. & Ringold, G. (1991) Identification of two distinct nuclear factors with DNA binding activity within the glucocorticoid regulatory region of the rat alpha-1-acid glycoprotein promoter, Biochem. Biophys. Res. Commun. 176, 1326-1332.
48. Oshima, H. & Simons, S. S. J. (1992) Modulation of transcription factor activity by a distant steroid modulatory element, Mol. Endocrinol. 6, 416-428.
49. Oshima, H. & Simons, S. S. J. (1993) Sequence-selective interactions of transcription factor elements with tandem glucocorticoid-responsive elements at physiological steroid concentrations, J. Biol. Chem. 268, 26858-26865.
50. Simons, S. S. J., Oshima, H. & Szapary, D. (1992) Higher levels of control: modulation of steroid hormone-regulated gene transcription, Mol. Endocrinol. 6, 995-1002.
51. Archer, T. K., Lefebvre, P., Wolford, R. G. & Hager, G. L. (1992) Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation, Science 255, 1573-1576.
52. Pina, B., Brüggemeier, U. & Beato, M. (1990) Nucleosome positioning modulates accessibility of regulatory proteins to the mouse mammary tumor virus promoter, Cell 60, 719-731.
53. Rigaud, G., Roux, J., Pictet, R. & Grange, T. (1991) In vivo foot-printing of rat TAT gene: dynamic interplay between the glucocorticoid receptor and a liver specific factor, Cell 67, 977-986.
54. Harnish, D. C., Malik, S. & Karathanasis, S. K. (1994) Activation of apolipoprotein A-I gene transcription by the liver-enriched factor HNF-3, J. Biol. Chem. 269, 28220-28226.
55. Diamond, M. I., Miner, J. N., Yoshinaga, S. K. & Yamamoto, K. R. (1990) Transcription factor interactions: selectors of positive or negative regulation from a single DNA element, Science 249, 1266-1272.
56. Rangurajan, P. N., Umesono, K. & Evans, R. M. (1992) Modulation of glucocorticoid receptor function by protein kinase A, Mol. Endocrinol. 6, 1451-1457.
57. Reik, A., Stewart, F. & Schütz, G. (1994) Cross-talk modulation of signal transduction pathways: two mechanisms are involved in the control of tyrosine aminotransferase gene expression by phorbol esters, Mol. Endocrinol. 8, 490-497.
58. Espinas, M. L., Roux, J., Pictet, R. & Grange, T. (1995) Glucocorticoids and protein kinase A coordinately modulate transcription factor recruitment at a glucocorticoid-responsive unit, Mol. Cell. Biol. 15, 5346-5354.
59. Vu-Dac, N., Schoonjans, K., Laine, B., Fruchart, J. C., Auwerx, J. & Staels, B. (1994) Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element, J. Biol. Chem. 269, 31012-31018.
60. Widom, R. L., Rhee, M. & Karathanasis, S. K. (1992) Repression by ARP-1 sensitizes apolipoprotein A-I gene responsiveness to RXRα and retinoic acid, Mol. Cell. Biol. 12, 3380-3389.
61. Ladias, J. A. A. & Karathanasis, S. K. (1991) Regulation of the apolipoprotein A-I gene by ARP-1, a novel member of steroid receptor superfamily, Science 251, 561-565.
62. Kilbourne, E. J., Widom, R., Harnish, D. C., Malik, S. & Karathanasis, S. K. (1995) Involvement of early growth response factor Egr-1 in apolipoprotein A-I gene transcription, J. Biol. Chem. 270, 7004-7010.
63. Berthou, L., Saladin, R., Yaqoob, P., Calder, P., Fruchart, J. C., Denefle, P., Auwerx, J. & Staels, B. (1995) Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II, and acyl-CoA oxidase gene expression by fibrates and dietary fatty acids, Eur. J. Biochem. 232, 179-187.